Wikidata

(Q63571495)

English

A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
A Phase 3b Open-label, Multicenter, Safety and Efficacy Extension Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Subjects With Hemophilia B (English)
0 references
medical condition
hemophilia A
0 references
hemophilia B
0 references
sponsor
CSL Behring
0 references
country
Australia
0 references
Austria
0 references
Bulgaria
0 references
Canada
0 references
France
0 references
Germany
0 references
Israel
0 references
Italy
0 references
Japan
0 references
Malaysia
0 references
Philippines
0 references
South Africa
0 references
Spain
0 references
start time
6 February 2014
0 references
end time
30 March 2020
0 references
number of participants
115
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63571495&oldid=2235111993"